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An understanding of the neurobiology of schizophrenia
and bipolar disorder has implications for treatment and
outcome. The neurodevelopmental hypothesis of schizo-
phrenia is of greatest importance in the neurobiological
understanding of the aetiopathogenesis of schizophrenia.
This hypothesis focuses on insults to prenatal brain devel-
opment, which lead to brain alterations. Premorbid cog-
nitive disturbances as well as behavioural abnormalities
are interpreted as vulnerability markers in the context of
this neurodevelopmental theory and are seen as a conse-
quence of the premorbid brain alterations. Given the fact
that heritability alone cannot explain schizophrenia or
bipolar disorder, nongenetic factors impairing develop-
ment must also be part of a multifactorial aetiopathogen-
esis of these disorders. The neurodevelopmental models
have varied considerably with respect to specificity and
timing of hypothesized genetic and environmental “hits”.
In recent years longitudinal brain imaging studies of both
early and adult onset populations with schizophrenia
indicate that progressive brain changes are more dynamic
than previously thought, with grey matter volume loss
particularly striking in adolescence and appearing to be an
exaggeration of the normal developmental pattern. This
supports an extended time period of abnormal neurode-
velopment in schizophrenia in addition to earlier
“lesions”. In schizophrenia, grey matter decreases have
been detected in temporal lobes, hippocampus, frontal
lobes, thalamus, amygdala and cingulate, and abnormali-
ties in prefrontal white matter, corpus callosum and the
Posterior superior temporal gyrus. It is of special interest
that schizophrenia susceptibility genes and chromosomal
abnormalities, particularly examined for early onset pop-
ulations, are associated with premorbid neurodevelop-
mental abnormalities. Postmortem human brain and
developmental animal studies document multiple and
diverse effects of developmental genes (including schizo-
phrenia susceptibility genes) at sequential stages of brain
development. Increased specificity for the most relevant
environmental risk factors such as exposure to prenatal
infection, and their interaction with susceptibility genes
and/or action through phase-specific altered gene expres-
sion, now both strengthen and modify the neurodevelop-
mental theory of schizophrenia.
Structural neuroimaging studies of bipolar disorder
patients have found increased white matter hyperintensi-
ties in periventricular white matter, frontal lobes, and
basal ganglia.
These abnormalities occur more commonly in bipolar
disorders than in schizophrenia. Evidence suggests
reduced grey matter in prefrontal brain regions and ante-
rior thalamus, and volume changes have also been found
in the amygdala and hippocampus. Multiple cases of
schizophrenia, bipolar disorder and concurrent psychosis
and mood disorder occur in some families. There is statis-
tically significant evidence that bipolar disorder occurs at
an increased rate in relatives of schizophrenic probands
and in the relatives of bipolar probands. Susceptibility
genes have been found, some specific to schizophrenia,
some to bipolar disorder and yet others that influence sus-
ceptibility to schizoaffective disorder, schizophrenia and
bipolar disorder.
In the past years, in addition to the neurodevelopmental
disorder a neuroprogressive brain disorder has been
under discussion to explain the decline especially in the
poor outcome subgroup of schizophrenic patients. This
presentation will discuss the available findings about sim-
ilarities and distinctions in the neurobiology of schizo-
phrenia and bipolar disorder.
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